Impaired eIF2B activity in ligodendrocytes contributes to VWMD pathogenesis

Neural Regeneration Research

Volumn 10, Issue 2, 2015, Pages 195-197

  Lin, Wensheng ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AP 20187; FK 506 BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LIGAND; PANCREATIC ENDOPLASMIC RETICULUM KINASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN KINASE; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; IMMUNOREACTIVITY; LOSS OF FUNCTION MUTATION; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; TRANSLATION REGULATION; VANISHING WHITE MATTER DISEASE;

EID: 84925147662     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.152366     Document Type: Article

References (10)

1. Bugiani M, Postma N, Polder E, Dieleman N, Scheffer PG, Sim FJ, van der Knaap MS, Boor I (2013) Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease. Brain 136:209-222.
2. Geva M, Cabilly Y, Assaf Y, Mindroul N, Marom L, Raini G, Pinchasi D, Elroy-Stein O (2010) A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter. Brain 133:2448-2461.
3. Lin W, Popko B (2009) Endoplasmic Reticulum stress in disorders of myelinating cells. Nat Neurosci 12:379-385.
4. Lin W, Lin Y, Li J, Fenstermaker AG, Way SW, Clayton B, Jamison S, Harding HP, Ron D, Popko B (2013) Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci 33:5980-5991.
5. Lin Y, Huang G, Jamison S, Li J, Harding HP, Ron D, Lin W (2014a) PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. Am J Pathol 184:507-519.
6. Lin Y, Pang X, Huang G, Jamison S, Fang J, Harding HP, Ron D, Lin W (2014b) Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice. J Neurosci 34:12182-12191.
7. Pavitt GD, Proud CG (2009) Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease. Biochem Soc Trans 37:1298-1310.
8. van derKnaap MS, Pronk JC, Scheper GC (2006) Vanishing white matter disease. Lancet Neurol 5:413-423.
9. van der Voorn JP, van Kollenburg B, Bertrand G, Van Haren K, Scheper GC, Powers JM, van der Knaap MS (2005) The unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol 64:770-775.
10. Wang S, Bates J, Li X, Schanz S, Chandler-Militello D, Levine C, Maherali N, Studer L, Hochedlinger K, Windrem M, Goldman SA (2013) Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12:252-264.